The Edible Mushroom Pleurotus spp.: II. Medicinal Values

Masri, H.; Maftoun, Parisa; Malek, Roslinda Abd; Boumehira, Ali Zineddine; Pareek, Avnish; Hanapi, Siti Zulaiha; Ling, Ong Mei; Enshasy, Hesham El

doi:10.6000/1927-3037.2017.06.01.1

Cited by 12 publications

(1 citation statement)

References 75 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The antitumor effect of these mushroom products was related to biomolecules including glucans, ergosterol, proteoglucans and amino acids (arginine and glutamine) [ 23 ]. The postulated mechanism underlying this effect may include the stimulation of T-lymphocytes, suppression of neovascularization and induction of cancer cell death, in addition to triggering the immune response against cancer cells [ 24 , 25 ].…”

Section: Introductionmentioning

confidence: 99%

Proteome Analysis and In Vitro Antiviral, Anticancer and Antioxidant Capacities of the Aqueous Extracts of Lentinula edodes and Pleurotus ostreatus Edible Mushrooms

et al. 2021

View full text Add to dashboard Cite

In this study, we examined aqueous extracts of the edible mushrooms Pleurotus ostreatus (oyster mushroom) and Lentinula edodes (shiitake mushroom). Proteome analysis was conducted using LC-Triple TOF-MS and showed the expression of 753 proteins by Pleurotus ostreatus, and 432 proteins by Lentinula edodes. Bioactive peptides: Rab GDP dissociation inhibitor, superoxide dismutase, thioredoxin reductase, serine proteinase and lectin, were identified in both mushrooms. The extracts also included promising bioactive compounds including phenolics, flavonoids, vitamins and amino acids. The extracts showed promising antiviral activities, with a selectivity index (SI) of 4.5 for Pleurotus ostreatus against adenovirus (Ad7), and a slight activity for Lentinula edodes against herpes simplex-II (HSV-2). The extracts were not cytotoxic to normal human peripheral blood mononuclear cells (PBMCs). On the contrary, they showed moderate cytotoxicity against various cancer cell lines. Additionally, antioxidant activity was assessed using DPPH radical scavenging, ABTS radical cation scavenging and ORAC assays. The two extracts showed potential antioxidant activities, with the maximum activity seen for Pleurotus ostreatus (IC50 µg/mL) = 39.46 ± 1.27 for DPPH; 11.22 ± 1.81 for ABTS; and 21.40 ± 2.20 for ORAC assays. This study encourages the use of these mushrooms in medicine in the light of their low cytotoxicity on normal PBMCs vis à vis their antiviral, antitumor and antioxidant capabilities.

show abstract

Section: Introductionmentioning

confidence: 99%